[go: up one dir, main page]

DE69535850D1 - Enterale zusammensetzung mit ribo-nucleotiden - Google Patents

Enterale zusammensetzung mit ribo-nucleotiden

Info

Publication number
DE69535850D1
DE69535850D1 DE69535850T DE69535850T DE69535850D1 DE 69535850 D1 DE69535850 D1 DE 69535850D1 DE 69535850 T DE69535850 T DE 69535850T DE 69535850 T DE69535850 T DE 69535850T DE 69535850 D1 DE69535850 D1 DE 69535850D1
Authority
DE
Germany
Prior art keywords
formula
enteral composition
nucleotide equivalents
nucleotides
ribo nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535850T
Other languages
English (en)
Inventor
Marc Leif Masor
James Lee Leach
Bruce Edward Molitor
John Durand Benson
Jeffrey Harris Baxter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/178,685 external-priority patent/US5488039A/en
Priority claimed from US08/178,687 external-priority patent/US5492899A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69535850D1 publication Critical patent/DE69535850D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13Nucleic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69535850T 1994-01-10 1995-01-05 Enterale zusammensetzung mit ribo-nucleotiden Expired - Lifetime DE69535850D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/178,685 US5488039A (en) 1994-01-10 1994-01-10 Method for the production of an enteral formula containing ribo-nucleotides
US08/178,687 US5492899A (en) 1994-01-10 1994-01-10 Infant nutritional formula with ribo-nucleotides
PCT/US1995/000090 WO1995018618A2 (en) 1994-01-10 1995-01-05 Enteral formula with ribo-nucleotides

Publications (1)

Publication Number Publication Date
DE69535850D1 true DE69535850D1 (de) 2008-11-13

Family

ID=26874551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535850T Expired - Lifetime DE69535850D1 (de) 1994-01-10 1995-01-05 Enterale zusammensetzung mit ribo-nucleotiden

Country Status (10)

Country Link
EP (1) EP0739207B1 (de)
JP (1) JP3033911B2 (de)
AT (1) ATE409483T1 (de)
AU (1) AU702304B2 (de)
CA (1) CA2180464C (de)
DE (1) DE69535850D1 (de)
DK (1) DK0739207T3 (de)
HK (1) HK1011610A1 (de)
NZ (2) NZ278778A (de)
WO (1) WO1995018618A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3976997A (en) * 1996-08-13 1998-03-06 Bristol-Myers Squibb Company Nutritional formulas supplemented with nucleotides, and processes thereof
DE50303452D1 (de) 2002-10-17 2006-06-29 Suedzucker Ag Verfahren zur Herstellung einer Isomaltulose-haltigen Enteralnahrung
US8815279B2 (en) 2003-02-10 2014-08-26 University College London Baby feeding formula and system
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
ES2219182B1 (es) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez Procedimiento para compensar el efecto negativo en la salud de alimentos que contienen azucar refinado.
JP4482493B2 (ja) * 2005-06-29 2010-06-16 明治飼糧株式会社 ロタウイルス感染・増殖抑制剤
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
JP2011507518A (ja) * 2007-12-20 2011-03-10 アボット・ラボラトリーズ 安定な栄養粉末
US8361534B2 (en) * 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
ES2660037T3 (es) * 2010-06-28 2018-03-20 Nestec S.A. Composiciones nutritivas hipocalóricas, de alto contenido en proteínas y procedimientos para su utilización
WO2022144799A1 (en) * 2020-12-30 2022-07-07 Pharsmart S.R.L. Immunostimulating food supplement and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303692A (en) * 1978-11-22 1981-12-01 Gaull Gerald E Infant milk formula
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
FR2693876A1 (fr) * 1992-07-24 1994-01-28 Vani Complément nutritif à base de micronutriments.
US6764693B1 (en) * 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants

Also Published As

Publication number Publication date
CA2180464A1 (en) 1995-07-13
HK1011610A1 (en) 1999-07-16
JPH09501181A (ja) 1997-02-04
ATE409483T1 (de) 2008-10-15
NZ278778A (en) 1998-10-28
MX9602693A (es) 1998-06-30
EP0739207A1 (de) 1996-10-30
NZ331481A (en) 2000-02-28
WO1995018618A2 (en) 1995-07-13
DK0739207T3 (da) 2008-12-15
AU1522295A (en) 1995-08-01
JP3033911B2 (ja) 2000-04-17
AU702304B2 (en) 1999-02-18
CA2180464C (en) 2001-08-14
WO1995018618A3 (en) 1995-10-05
EP0739207B1 (de) 2008-10-01

Similar Documents

Publication Publication Date Title
MX9602692A (es) Metodo para incrementar el sistema inmune humano.
DE69535850D1 (de) Enterale zusammensetzung mit ribo-nucleotiden
BAKER et al. Vitamin B6Requirement for Adult Men
Maitra et al. The role of DNA in RNA synthesis, IX. Nucleoside triphosphate termini in RNA polymerase products.
MX9709859A (es) Inhibidores de adenosina cinasa modificados en c-4.
DK1001685T3 (da) Næringsmiddelsammensætning indeholdende methionin
ATE246455T1 (de) Kohlenhydratmischung
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
ATE220859T1 (de) Kaloriereiche ernährungszusammensetzung
ZA86413B (en) High fat,low carbohydrate enteral nutritional formula
ES2191291T3 (es) Complejos de boro con carbohidratos y aplicaciones de los mismos.
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
CA2299729A1 (en) Improved infant formula and methods of improving infant stool patterns
DK0736256T3 (da) Enantiomert-berigede ernæringsmæssige energisubstrater
GB2216416A (en) Immunostimulating compositions comprising nucleobase sources
JPS5799194A (en) Sucrose mutase
NZ214616A (en) Pharmaceutical compositions containing uridine-diphosphoglucose(udpg)
Oace et al. Urinary Aminoimidazolecarboxamide in the Rat as Influenced by Dietary Vitamin B12, Methionine and Thyroid Powder123
Wadler et al. Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cells
ATE431080T1 (de) Fischfutter mit erhöhtem gehalt an nukleotiden
Ortiz The inhibition of E. coli adenyl cyclase by ara ATP
Stein et al. Nucleotides may have a role in nutrition of young pigs
Smith et al. Enhancement by adenine of the inhibition of Salmonella typhimurium by ethionine
EP0320807A3 (de) Nucleinsäure-Analoge, Verfahren zur Inhibition von Nucleinsäure-Polymerasen und Verfahren zur Induktion der Synthese von Interferon
Musa Imipramine: Relationship of age to steady-state plasma level in endogenous depression.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition